Barbara L. McAneny, MD, FASCO, MACP, a board-certified medical oncologist/hematologist from Albuquerque, NM, became the 173rd president of the American Medical Association (AMA) in June 2018, serving as its chair in 2015–2016. Dr. McAneny is a fellow and former member of the board of directors of the American Society of Clinical Oncology (ASCO), a master of the American College of Physicians, and a past president of the New Mexico Medical Society (NMMS), the Greater Albuquerque Medical Association, and the New Mexico chapter of the American College of Physicians. In addition, she has served as a member of the Community Oncology Alliance Board of Trustees and on the board of directors of the Cancer Center Business Summit. She became the delegate to the AMA from ASCO in 2002 and was elected to the AMA Council on Medical Service in 2003, serving as its chair in 2009–2010.

Dr. McAneny is one of the founders and current chair of the board of the National Cancer Care Alliance, a group of independent practices collaborating to use innovation to deliver high-quality, high-value cancer care and to develop new alternative payment models based on sound data-driven principles. Prior to this, she was a founding member of Oncology Circle, a group of oncology practices using data to promote best practices. Dr. McAneny’s interest in using data to improve practice sustainability began when she was appointed to the Centers for Medicare & Medicaid Services' Practicing Physicians Advisory Council, where she served from 2002 to 2006. In 2012, Dr. McAneny received a $19.8 million grant from the Centers for Medicare & Medicaid Innovation to demonstrate how oncology practices could use triage pathways to dramatically lower costs while improving outcomes. This award, named COME HOME (for Community Oncology Medical Home), later was incorporated into Medicare’s Oncology Care Model. Dr. McAneny also cofounded New Mexico Oncology Hematology Consultants Ltd. in 1987 with Clark Haskins, MD. A managing partner since 1999, she built New Mexico Cancer Center as the first physician-owned multidisciplinary cancer center in the state with clinics in Albuquerque and Gallup. She also founded the New Mexico Cancer Center Foundation, which provides grants to help patients with non-medical expenses.

Dr. McAneny graduated magna cum laude from the University of Minnesota in 1973 and with honors from the University of Iowa College of Medicine in 1977. She completed her residency in internal medicine at the University of Iowa in 1980 and her fellowship in hematology/oncology at the University of New Mexico in 1983. 

Dr. Fontaine is Chief Medical Officer for New Mexico Oncology Hematology Consultants, Ltd in Albuquerque. NMCC was the first practice in the nation to receive accreditation as an Oncology Medical Home by NCQA. And their commitment to excellence has also helped them earn the title of “Top Cancer Center” by readers of the Albuquerque Journal twice in the last three years.

Dr. Fontaine joined the practice in 2006, and she is board Certified in Medical Oncology and Hematology and is certified by City of Hope for cancer genetics. Dr. Fontaine also holds a Physician Executive MBA from the University of Tennessee.  Dr. Fontaine’s peers throughout the Albuquerque medical community recognize both her dedication to her patients and her expertise as a clinician, and they have voted her “Top Medical Oncologist” in Albuquerque the Magazine’s Top Docs poll seven times, with her most-recent win in 2019.

Dr. Fontaine is a member of the American Medical Association and the American Society of Clinical Oncology.  She devotes her spare time to educating her peers and patients on hereditary cancer risk in addition to playing the piano and hiking.

James Randle Adair, DO, PhD, completed his postdoctoral fellowships in biomedical engineering at John Hopkins University and pharmacology at Georgetown University School of Medicine. After completing medical training, he served as faculty at the University of South Alabama until moving to New Mexico.

Since 2004, Dr. Adair has been involved in researching thrombosis prevention and treatment, patient safety initiatives at both Presbyterian Hospital and the VA Hospital in Albuquerque, and teaching on the proper use, efficacy, and safety of newer anticoagulants.